FDA: Don ' t Use Azithromycin for Lung Condition in Cancer Patients FDA: Don ' t Use Azithromycin for Lung Condition in Cancer Patients

The FDA warns of an increased risk for relapse of hematologic malignancy and for death when azithromycin is used to prevent bronchiolitis obliterans syndrome in hematopoietic stem cell transplant patients.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news